Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. C. Strum
Preclinical Characterization of G1T28: A Novel CDK4/6 Inhibitor for Reduction of Chemotherapy-Induced Myelosuppression
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
A Novel Tankyrase Inhibitor, MSC2504877, Enhances the Effects of Clinical CDK4/6 Inhibitors
Scientific Reports
Multidisciplinary
Cdk4/6-Inhibitor as a Novel Therapeutic Approach for Advanced Bladder Cancer Independently of RB1 Status
Clinical Cancer Research
Cancer Research
Oncology
A Combination CDK4/6 and IGF1R Inhibitor Strategy for Ewing Sarcoma
Clinical Cancer Research
Cancer Research
Oncology
Preclinical Evaluation of Exemestane as a Novel Chemotherapy for Gastric Cancer
Journal of Cellular and Molecular Medicine
Molecular Medicine
Cell Biology
Preclinical Validation of AR42, a Novel Histone Deacetylase Inhibitor, as Treatment for Vestibular Schwannomas
Laryngoscope
Otorhinolaryngology
P16 Methylation Increases the Sensitivity of Cancer Cells to the CDK4/6 Inhibitor Palbociclib
PLoS ONE
Multidisciplinary
Effects of Interleukin-3 on Myelosuppression Induced by Chemotherapy for Ovarian Cancer and Small Cell Undifferentiated Tumours
British Journal of Cancer
Cancer Research
Oncology
Preclinical Antitumor Activity of SST0116CL1: A Novel Heat Shock Protein 90 Inhibitor
International Journal of Oncology
Cancer Research
Oncology
Direct CDKN2 Modulation of CDK4 Alters Target Engagement of CDK4 Inhibitor Drugs.
Molecular Cancer Therapeutics
Cancer Research
Oncology